BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2001
View Archived Issues
Genome-derived candidate for oncology identified as part of Millennium/Bayer alliance
Read More
Telik and the University of Arizona enter TRAP alliance
Read More
Human Genome Sciences licenses protein purification technology from Dyax
Read More
Update on Active Biotech's TTS products under clinical development
Read More
GlaxoSmithKline acquisition of Block Drug completed
Read More
Biogen expects product pipeline to double during 2001
Read More
Vion provides update of clinical programs
Read More
Results of phase III Metvix study show superiority to cryotherapy in treatment of AK
Read More
FDA approves Remeron SolTab for treatment of depression
Read More
Atrisone advances to phase III testing in acne
Read More
Continuous combined HRT with Climodien cleared for marketing in The Netherlands
Read More
Development of Merck compound for PD discontinued
Read More
Details on proposed merger of Medi-Ject and Permatec
Read More
Arakis and Bioglan Pharma to jointly develop novel psoriasis treatment
Read More
Pagoclone enters phase II for treatment of GAD
Read More
Arena receives second milestone payment from Lilly in CART collaboration
Read More
IntraBiotics completes patient enrollment in phase III Protegrin IB-367 Rinse study
Read More
Antex receives SBIR grant to develop microbead vaccine for traveler's diarrhea
Read More
Exclusive rights to NX-211 obtained by Gilead from GSK
Read More
First tablet preparation for bowel cleansing prior to colonoscopy now available in U.S.
Read More
Newly designed HIV-1 entry inhibitor holds great promise for clinical application
Read More
Monoclonal antibodies to alpha1 integrin designed at Biogen for inflammatory disorders
Read More
Adenosine uptake inhibitors useful for cerebral ischemia patented by Bayer
Read More
New oxazaheterocyle-based protease inhibitors reported by 3DP group
Read More
Antimicrobial series in development at Pharmacia
Read More
Anticancer compounds from Boehringer Ingelheim acting on kinases
Read More
Novel tryptase inhibitors with potential in therapy of influenza
Read More